Pathogenesis of type 1 diabetes: Lessons from natural history studies of high-risk individuals

Annals of the New York Academy of Sciences

Volumn 1281, Issue 1, 2013, Pages 1-15

  Nokoff, Natalie ^a   Rewers, Marian ^a,b  

^a University of Colorado Denver and Children s Hospital Colorado   (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

Autoimmune; Beta cell; Islet autoantibody; Type 1 diabetes

Indexed keywords

AUTOANTIBODY; C PEPTIDE; GLUTAMATE DECARBOXYLASE ANTIBODY; HLA A ANTIGEN; HLA B ANTIGEN; HLA C ANTIGEN; HLA DP ANTIGEN; HLA DPB1 ANTIGEN; HLA DQ ANTIGEN; HLA DQA1 ANTIGEN; HLA DQB1 ANTIGEN; HLA DR ANTIGEN; HLA DR3 ANTIGEN; HLA DR4 ANTIGEN; HLA DRB1 ANTIGEN; INSULIN AUTOANTIBODY; INSULINOMA ASSOCIATED PROTEIN 2 AUTOANTIBODY; NON RECEPTOR PROTEIN TYROSINE PHOSPHATASE 22; PREPROINSULIN; PROTEIN ANTIBODY; UNCLASSIFIED DRUG; ZINC TRANSPORTER 8 ANTIBODY;

ARTICLE; AUTOIMMUNITY; BODY WEIGHT; CHROMOSOME 11; CHROMOSOME 6P; DNA METHYLATION; ENVIRONMENTAL FACTOR; EPIGENETICS; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; HIGH RISK POPULATION; HLA SYSTEM; HUMAN; IMMUNE RESPONSE; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RESISTANCE; MASS SPECTROMETRY; NONHUMAN; PANCREAS ISLET; PATHOGENESIS; PROTEIN INTERACTION; PROTEIN PROCESSING; SEROCONVERSION; STRATIFIED SAMPLE; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY;

EID: 84875636480     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/nyas.12021     Document Type: Article

References (132)

1. Eisenbarth, G.S. 2005. Type 1 diabetes: cellular, molecular and clinical immunology. Kluwer Academic/Plenum. Dordrecht.
2. Vehik, K., R.F. Hamman, D. Lezortte, et al. 2007. Increasing incidence of type 1 diabetes in 0- to 17-year-old Colorado youth. Diabetes Care 30: 503-509.
3. Diabetes Epidemiology Research International Group. 1990. Secular trends in incidence of childhood IDDM in 10 countries. Diabetes 39: 858-864.
4. Patterson, C.C., G.G. Dahlquist, E. Gyürüs, et al. 2009. Incidence trends for childhood type 1 diabetes in Europe during 1989-2003 and predicted new cases 2005-20: a multicentre prospective registration study. Lancet 373: 2027-2033.
5. Mayer-Davis, E., D. Dabelea, J.W. Talton, et al. 2012. Increase in prevalence of type 1 diabetes from the SEARCH for Diabetes in Youth Study: 2001-2009. Diabetes 61(Suppl1): A322.
6. Barker, J.M., K.J. Barriga, L. Yu, et al. 2004. Prediction of autoantibody positivity and progression to type 1 diabetes: Diabetes Autoimmunity Study in the Young (DAISY). J. Clin. Endocrinol. Metab. 89: 3896-3902.
7. Ziegler, A.G., M. Hummel, M. Schenker, et al. 1999. Autoantibody appearance and risk for development of childhood diabetes in offspring of parents with type 1 diabetes: the 2-year analysis of the German BABYDIAB Study. Diabetes 48: 460-468.
8. Nejentsev, S., M. Sjöroos, T. Soukka, et al. 1999. Population-based genetic screening for the estimation of Type 1 diabetes mellitus risk in Finland: selective genotyping of markers in the HLA-DQB1, HLA-DQA1 and HLA-DRB1 loci. Diabet. Med. 16: 985-992.
9. Kimpimäki, T., P. Kumala, K. Savola, et al. 2002. Natural history of β-cell autoimmunity in young children with increased genetic susceptibility to type 1 diabetes recruited from the general population. J. Clin. Endocrinol. Metab. 87: 4572-4579.
10. Barker, J.M., S.H. Goehrig, K. Barriga, et al. 2004. Clinical characteristics of children diagnosed with type 1 diabetes through intensive screening and follow-up. Diabetes Care 27: 1399-1404.
11. Silva, D.G., S.R. Daley, J. Hogan, et al. 2011. Anti-islet autoantibodies trigger autoimmune diabetes in the presence of an increased frequency of islet-reactive CD4 T cells. Diabetes 60: 2102-2111.
12. Palmer, J.P., C.M. Asplin, P. Clemons, et al. 1983. Insulin antibodies in insulin-dependent diabetics before insulin treatment. Science 222: 1337-1339.
13. Baekkeskov, S., H.J. Aanstoot, S. Christgau, et al. 1990. Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase. Nature 347: 151-156.
14. Bonifacio, E., V. Lampasona, S. Genovese, et al. 1995. Identification of protein tyrosine phosphatase-like IA2 (islet cell antigen 512) as the insulin-dependent diabetes-related 37/40K autoantigen and a target of islet-cell antibodies. J. Immunol. 155: 5419-5426.
15. Wenzlau, J.M., K. Juhl, O. Moua, et al. 2007. The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetes. Proc. Natl. Acad. Sci. USA 104: 17040-17045.
16. Dabelea, D., C. Pihoker, J.W. Talton, et al. 2011. Etiological approach to characterization of diabetes type: the SEARCH for diabetes in youth study. Diabetes Care 34: 1628-1633.
17. Savola, K., E. Bonifacio, E. Sabbah, et al. 1998. IA-2 antibodies-a sensitive marker of IDDM with clinical onset in childhood and adolescence. Childhood Diabetes in Finland Study Group. Diabetologia 41: 424-429.
18. Knip, M., S. Korhonen, P. Kumala, et al. 2010. Prediction of type 1 diabetes in the general Population. Diabetes Care 33: 1206-1212.
19. Kawasaki, E., K. Nakamura, G. Kuriya, et al. 2011. Zinc transporter 8 autoantibodies in fulminant, acute-onset, and slow-onset patients with type 1 diabetes. Diabetes Metab. Res. Rev. 27: 895-898.
20. Steck, A.K., K.J. Barriga, L.M. Emery, et al. 2005. Secondary attack rate of type 1 diabetes in Colorado families. Diabetes Care 28: 296-300.
21. Stanley, H.M., J.M. Norris, K. Barriga, et al. 2004. Is presence of islet autoantibodies at birth associated with development of persistent islet autoimmunity? Diabetes Care 27: 497-502.
22. Ziegler, A.G., B. Hillebrand, W. Rabl, et al. 1993. On the appearance of islet associated autoimmunity in offspring of diabetic mothers: a prospective study from birth. Diabetologia 36: 402-408.
23. Roll, U., M.R. Christie, M. Füchtenbusch, et al. 1996. Perinatal autoimmunity in offspring of diabetic parents. The German multicenter BABY-DIAB study: detection of humoral immune responses to islet antigens in early childhood. Diabetes 45: 967-973.
24. Hämäläinen, A.M., M.S. Ronkainen, H.K. Akerblom, et al. 2000. Postnatal elimination of transplacentally acquired disease-associated antibodies in infants born to families with type 1 diabetes. J. Clin. Endocrinol. Metab. 85: 4249-4253.
25. Naserke, H., E. Bonifacio & A.G. Ziegler. 2001. Prevalence, characteristics and diabetes risk associated with transient maternally acquired islet antibodies and persistent islet antibodies in offspring of parents with type 1 diabetes. J. Clin. Endocrinol. Metab. 86: 4826-4833
26. Koczwara, K., E. Bonifacio & A.G. Ziegler. 2004. Transmission of maternal islet antibodies and risk of autoimmune diabetes in offspring of mothers with type 1 diabetes. Diabetes 53: 1-4.
27. Warram, J.H., A.S. Krolewski, M.S. Gottlieb, et al. 1984. Differences in risk of insulin-dependent diabetes in offspring of diabetic mothers and diabetic fathers. N. Engl. J. Med. 311: 149-152.
28. The Eurodiab Ace Study Group and The Eurodiab Ace Substudy 2 Study Group. 1998. Familial risk of type I diabetes in European children. Diabetologia 41: 1151-1156.
29. Harjutsalo, V., A. Reunanen & J. Tuomilehto. 2006. Differential transmission of type 1 diabetes from diabetic fathers and mothers to their offspring. Diabetes 55: 1517-1524.
30. Bonifacio, E., M. Pflüger, S. Marienfeld, et al. 2008. Maternal type 1 diabetes reduces the risk of islet autoantibodies: relationships with birthweight and maternal HbA(1c). Diabetologia 51: 1245-1252.
31. Greeley, S.A., M. Katsumata, L. Yu, et al. 2002. Elimination of maternally transmitted autoantibodies prevents diabetes in nonobese diabetic mice. Nat. Med. 8: 399-402.
32. Verge, C.F., R. Gianani, E. Kawasaki, et al. 1996. Number of autoantibodies (against insulin, GAD or ICA512/IA2) rather than particular autoantibody specificities determines risk of type I diabetes. J. Autoimmun. 9: 379-383.
33. Verge, C.F., R. Gianani, E. Kawasaki, et al. 1996. Prediction of type I diabetes in first-degree relatives using a combination of insulin, GAD, and ICA512bdc/IA-2 autoantibodies. Diabetes 45: 926-933.
34. Steck, A.K., K. Johnson, K.J. Barriga, et al. 2011. Age of islet autoantibody appearance and mean levels of insulin, but not GAD or IA-2 autoantibodies, predict age of diagnosis of type 1 diabetes. Diabetes Care 34: 1397-1399.
35. Parikka, V., K. Näntö-Salonen, M. Saarinen, et al. 2012. Early seroconversion and rapidly increasing autoantibody concentrations predict prepubertal manifestation of type 1 diabetes in children at genetic risk. Diabetologia 55: 1926-1936.
36. Ziegler, A.G., E. Bonifacio & BABYDIAB-BABYDIET Study Group. 2012. Age-related islet autoantibody incidence in offspring of patients with type 1 diabetes. Diabetologia 55: 1937-1943.
37. Stene, L.C., K. Barriga, M. Hoffman, et al. 2006. Normal but increasing hemoglobin A1c levels predict progression from islet autoimmunity to overt type 1 diabetes: Diabetes Autoimmunity Study in the Young (DAISY). Pediatr. Diabetes 7: 247-253.
38. Steffes, M.W., S. Sibley, M. Jackson, et al. 2003. Beta-cell function and the development of diabetes-related complications in the diabetes control and complications trial. Diabetes Care 26: 832-836.
39. Orešič, M., S. Simell, M. Sysi-Aho, et al. 2008. Dysregulation of lipid and amino acid metabolism precedes islet autoimmunity in children who later progress to type 1 diabetes. J. Exp. Med. 205: 2975-2984.
40. Pflüger, M., T. Seppänen-Laakso, T. Suortti, et al. 2011. Age- and islet autoimmunity-associated differences in amino acid and lipid metabolites in children at risk for type 1 diabetes. Diabetes 60: 2740-2747.
41. Orešič, M., A. Vidal-Puig & V. Hänninen. 2006. Metabolomic approaches to phenotype characterization and applications to complex diseases. Expert Rev. Mol. Diagn. 6: 575-585.
42. Wishart, D.S., C. Knox, A.C. Guo, et al. 2009. HMDB: a knowledgebase for the human metabolome. Nucleic Acids Res. 37: D603-D610.
43. Mehta, D. 2005. Lysophosphatidylcholine: an enigmatic lysolipid. Am. J. Physiol. Lung Cell. Mol. Physiol. 289: L174-L175.
44. Niculescu, M.D., C.N. Craciunescu & S.H. Zeisel. 2006. Dietary choline deficiency alters global and gene-specific DNA methylation in the developing hippocampus of mouse fetal brains. FASEB J. 20: 43-49.
45. Dumas, M.E., R.H. Barton, A. Toye, et al. 2006. Metabolic profiling reveals a contribution of gut microbiota to fatty liver phenotype in insulin-resistant mice. Proc. Natl. Acad. Sci. USA 103: 12511-12516.
46. Wen, L., R.E. Ley, P.Y. Volchkov, et al. 2008. Innate immunity and intestinal microbiota in the development of type 1 diabetes. Nature 455: 1109-1113.
47. Niculescu, M.D. & S.H. Zeisel. 2002. Diet, methyl donors and DNA methylation: interactions between dietary folate, methionine and choline. J. Nutr. 132(Suppl): 2333S-2335S.
48. Nikkilä, J., M. Sysi-Aho, A. Ermolov, et al. 2008. Gender-dependent progression of systemic metabolic states in early childhood. Mol. Syst. Biol. 4: 197. Published online 2008, June 3. doi: 10.1038/msb.2008.34.
49. Lenz, E.M., J. Bright, I.D. Wilson, et al. 2004. Metabonomics, dietary influences and cultural differences: a 1H NMR-based study of urine samples obtained from healthy British and Swedish subjects. J. Pharm. Biomed. Anal. 36: 841-849.
50. Bäckhed, F., H. Ding, T. Want, et al. 2004. The gut microbiota as an environmental factor that regulates fat storage. Proc. Natl. Acad. Sci. USA 101: 15718-15723.
51. Beyan, H., L. Wen & R.D. Leslie. 2012. Guts, germs, and meals: the origin of type 1 diabetes. Curr. Diab. Rep. 12: 456-462.
52. Noble, J.A., A.M. Valdes, M. Cook, et al. 1996. The role of HLA class II genes in insulin-dependent diabetes mellitus: molecular analysis of 180 Caucasian, multiplex families. Am. J. Hum. Genet. 59: 1134-1148.
53. Rewers, M., T.L. Bugawan, J.M. Norris, et al. 1996. Newborn screening for HLA markers associated with IDDM: diabetes autoimmunity study in the young (DAISY). Diabetologia 39: 807-812.
54. Bonifacio, E., M. Hummel, M. Walter, et al. 2004. IDDM1 and multiple family history of type 1 diabetes combine to identify neonates at high risk for type 1 diabetes. Diabetes Care 27: 2695-2700.
55. Hagopian, W.A., H. Erlich, A. Lernmark, et al. 2011. The Environmental Determinants of Diabetes in the Young (TEDDY): genetic criteria and international diabetes risk screening of 421 000 infants. Pediatr. Diabetes 12: 733-743.
56. Valdes, A., H.A. Erlich, J. Carlson, et al. 2012. Use of class I and class II HLA loci for predicting age at onset of type 1 diabetes in multiple populations. Diabetologia 55: 2394-2401.
57. Nejentsev, S., J.M. Howson, N.M. Walker, et al. 2007. Localization of type 1 diabetes susceptibility to the MHC class I genes HLA-B and HLA-A. Nature 450: 887-892.
58. Tait, B.D., P.G. Colman, G. Morahan, et al. 2003. HLA genes associated with autoimmunity and progression to disease in type 1 diabetes. Tissue Antigens 61: 146-153.
59. Lipponen, K., Z. Gombos, M. Kiviniemi, et al. 2010. Effect of HLA class I and class II alleles on progression from autoantibody positivity to overt type 1 diabetes in children with risk-associated class II genotypes. Diabetes 59: 3253-3256.
60. Honeyman, M.C., L.C. Harrison, B. Drummond, et al. 1995. Analysis of families at risk for insulin-dependent diabetes mellitus reveals that HLA antigens influence progression to clinical disease. Mol. Med. 1: 576-582.
61. Bergholdt, R., C. Brorsson, A. Palleja, et al. 2012. Identification of novel type 1 diabetes candidate genes by integrating genome-wide association Data, protein-protein interactions, and human pancreatic islet gene expression. Diabetes 61: 954-962.
62. Concannon, P., S.S. Rich & G.T. Nepom. 2009. Genetics of type 1A diabetes. N. Engl. J. Med. 360: 1646-1654.
63. Steck, A.K., R. Wong, B. Wagner, et al. 2012. Effects of non-HLA gene polymorphisms on development of islet autoimmunity and type 1 diabetes in a population with high-risk HLA-DR, DQ genotypes. Diabetes 61: 753-758.
64. Lempainen, J., R. Hermann, R. Veijola, et al. 2012. Effect of the PTPN22 and INS risk genotypes on the progression to clinical type 1 diabetes after the initiation of β-cell autoimmunity. Diabetes 61: 963-966.
65. Bottini, N., L. Musumeci, A. Alonso, et al. 2004. A functional variant of lymphoid tyrosine phosphatase is associated with type I diabetes. Nat. Genet. 36: 337-338.
66. Cho, J.H. & P.K. Gregersen. 2011. Genomics and the multifactorial nature of human autoimmune disease. N. Engl. J. Med. 365: 1612-1623.
67. Steck, A.K., W. Zhang, T.L. Bugawan, et al. 2009. Do non-HLA genes influence development of persistent islet autoimmunity and type 1 diabetes in children with high-risk HLA-DR, DQ genotypes? Diabetes 58: 1028-1033.
68. Peng, H., M. Zhou, W.D. Wu, et al. 2012. Association of PTPN22 C1858T polymorphism and type 1 diabetes: a meta-analysis. Immunol. Invest. 41: 484-496.
69. Todd, J.A., N.M. Walker, J.D. Cooper, et al. 2007. Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes. Nat. Genet. 39: 857-864.
70. Bennett, S.T., A.M. Lucassen, S.C. Gough, et al. 1995. Susceptibility to human type 1 diabetes at IDDM2 is determined by tandem repeat variation at the insulin gene minisatellite locus. Nat. Genet. 9: 284-292.
71. Lucassen, A.M., C. Julier, J.P. Beressi, et al. 1993. Susceptibility to insulin dependent diabetes mellitus maps to a 4.1 kb segment of DNA spanning the insulin gene and associated VNTR. Nat. Genet. 4: 305-310.
72. Pugliese, A., M. Zeller, A. Fernandez, et al. 1997. The insulin gene is transcribed in the human thymus and transcription levels correlate with allelic variation at the INS VNTR-IDDM2 susceptibility locus for type 1 diabetes. Nat. Genet. 15: 293-297.
73. Vafiadis, P., S.T. Bennett, J.A. Todd, et al. 1997. Insulin expression in human thymus is modulated by INS VNTR alleles at the IDDM2 locus. Nat. Genet .15: 289-292.
74. Durinovic-Belló, I., E. Jelinek, M. Schloseer, et al. 2005. Class III alleles at the insulin VNTR polymorphism are associated with regulatory T-cell responses to proinsulin epitopes in HLA-DR4, DQ8 individuals. Diabetes 54: S18-S24.
75. Durinovic-Belló, I., R.P. Wu, V.H. Gersuk, et al. 2010. Insulin gene VNTR genotype associates with frequency and phenotype of the autoimmune response to proinsulin. Genes Immun. 11: 188-193.
76. Barratt, B.J., F. Payne, R. Hermann, et al. 2004. Remapping the insulin gene/IDDM2 locus in type 1 diabetes. Diabetes 53: 1884-1889.
77. Bjørnvold, M., D.E. Undlien, G. Joner, et al. 2008. Joint effects of HLA, INS, PTPN22 and CTLA4 genes on the risk of type 1 diabetes. Diabetologia 51: 589-596.
78. Awata, T., K. Kawasaki, H. Ikegami, et al. 2007. Insulin gene/IDDM2 Locus in Japanese type 1 diabetes: contribution of class I alleles and influence of class I subdivision in susceptibility to type 1 diabetes. J. Clin. Endocrinol. Metab. 92: 1791-1795.
79. Fendler, W., I. Klich, A. Cieślik-Heinrich, et al. 2011. Increased risk of type 1 diabetes in Polish children - association with INS-IGF2 5'VNTR and lack of association with HLA haplotype. Endokrynol. Pol. 62: 436-442.
80. Nakayama, M. 2011. Insulin as a key autoantigen in the development of type 1 diabetes. Diabetes Metab. Res. Rev. 27: 773-777.
81. Lempainen, J., O. Vaarala, M. Mäkelä, et al. 2009. Interplay between PTPN22 C1858T polymorphism and cow's milk formula exposure in type 1 diabetes. J. Autoimmun. 33: 155-164.
82. Liu, S., H. Wang, Y. Jin, et al. 2009. IFIH1 polymorphisms are significantly associated with type 1 diabetes and IFIH1 gene expression in peripheral blood mononuclear cells. Hum. Mol. Genet. 18: 358-365.
83. Kato, H., O. Takeuchi, S. Sato, et al. 2006. Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 441: 101-105.
84. Kato, H., O. Takeuchi, S. Sato, et al. 2006. Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 441: 101-105.
85. von Herrath, M. 2009. Diabetes: A virus-gene collaboration. Nature 459: 518-519.
86. Nejentsev, S., N. Walker, D. Riches, et al. 2009. Rare variants of IFIH1, a gene implicated in antiviral responses, protect against type 1 diabetes. Science 324: 387-389.
87. Yeung, W.C., W.D. Rawlinson & M.E. Craig. 2011. Enterovirus infection and type 1 diabetes mellitus: systematic review and meta-analysis of observational molecular studies. Br. Med. J. 342: d35.
88. Stene, L.C., S. Oikarinen, H. Hyöty, et al. 2010. Enterovirus infection and progression from islet autoimmunity to type 1 diabetes: the Diabetes and Autoimmunity Study in the Young (DAISY). Diabetes 59: 3174-3180.
89. Fumagalli, M., M. Sironi, U. Pozzoli, et al. 2011. Signatures of environmental genetic adaptation pinpoint pathogens as the main selective pressure through human evolution. PLoS Genet. 7: e1002355.
90. Javierre, B. M., H. Hernando & E. Ballestar. 2011. Environmental triggers and epigenetic deregulation in autoimmune disease. Discov. Med. 12: 535-545.
91. Neidhart, M., J. Rethage, S. Kuchen, et al. 2000. Retrotransposable L1 elements expressed in rheumatoid arthritis synovial tissue: association with genomic DNA hypomethylation and influence on gene expression. Arthritis Rheum. 43: 2634-2647.
92. Glória, L., M. Cravo, A. Pinto, et al. 1996. DNA hypomethylation and proliferative activity are increased in the rectal mucosa of patients with long-standing ulcerative colitis. Cancer 78: 2300-2306.
93. Zhang, P., Y. Su, H. Chen, et al. 2010. Abnormal DNA methylation in skin lesions and PBMCs of patients with psoriasis vulgaris. J. Dermatol. Sci. 60: 40-42.
94. Lei, W., Y. Luo, W. Lei, et al. 2009. Abnormal DNA methylation in CD4+ T cells from patients with systemic lupus erythematosus, systemic sclerosis, and dermatomyositis. Scand. J. Rheumatol. 38: 369-374.
95. Zhang, Z., L. Song, K. Maurer, et al. 2010. Global H4 acetylation analysis by ChIP-chip in systemic lupus erythematosus monocytes. Genes Immun. 11: 124-133.
96. Fradin, D., S. Le Fur, C. Mille, et al. 2012. Association of the CpG methylation pattern of the proximal insulin gene promoter with type 1 diabetes. PloS One 7: 1-8.
97. Rakyan, V.K., H. Beyan, T.A. Down, et al. 2011. Identification of type 1 diabetes-associated DNA methylation variable positions that precede disease diagnosis. PLoS Genet. 7: e1002300.
98. Miao, F., Z. Chen, L. Zhang, et al. 2012. Profiles of epigenetic histone post-translational modifications at type 1 diabetes susceptible genes. J. Biol. Chem. 287: 16335-16345.
99. DIAMOND Project Group. 2006. Incidence and trends of childhood type 1 diabetes worldwide 1990-1999. Diabees. Med .23: 857-866.
100. Rewers, M., R.E. LaPorte, M. Walczak, et al. 1987. Apparent epidemic of insulin-dependent diabetes mellitus in Midwestern Poland. Diabetes 36: 106-113.
101. Fleegler, F.M., K.D. Rogers, A. Drash, et al. 1979. Age, sex, and season of onset of juvenile diabetes in different geographic areas. Pediatrics 63: 374-379.
102. Kaprio, J., J. Tuomilehto, M. Koskenvuo, et al. 1992. Concordance for type 1 (insulin-dependent) and type 2 (non-insulin-dependent) diabetes mellitus in a population-based cohort of twins in Finland. Diabetologia 35: 1060-1067.
103. Kumar, D., N.S. Gemayel, D. Deapen, et al. 1993. North-American twins with IDDM. Genetic, etiological, and clinical significance of disease concordance according to age, zygosity, and the interval after diagnosis in first twin. Diabetes 42: 1351-1363.
104. Redondo, M.J., L. Yu, M. Hawa, et al. 2001. Heterogeneity of type I diabetes: analysis of monozygotic twins in Great Britain and the United States. Diabetologia 44: 354-362.
105. Hermann, R., M. Knip, R. Veijola, et al. 2003. Temporal changes in the frequencies of HLA genotypes in patients with Type 1 diabetes-indication of an increased environmental pressure? Diabetologia 46: 420-425.
106. Vehik, K., R.F. Hamman, D. Lezotte, et al. 2008. Trends in high-risk HLA susceptibility genes among Colorado youth with type 1 diabetes. Diabetes Care 31: 1392-1396.
107. Fourlanos, S., M.D. Varney, B.D. Tait, et al. 2008. The rising incidence of type 1 diabetes is accounted for by cases with lower-risk human leukocyte antigen genotypes. Diabetes Care 31: 1546-1549.
108. Ziegler, A.G., S. Schmid, D. Huber, et al. 2003. Early infant feeding and risk of developing type 1 diabetes-associated autoantibodies. JAMA 290: 1721-1728.
109. TEDDY Study Group. 2008. The Environmental Determinants of Diabetes in the Young (TEDDY) Study. Ann. N.Y. Acad. Sci. 150: 1-13.
110. Norris, J.M. 2010. Infant and childhood diet and type 1 diabetes risk: recent advances and prospects. Curr. Diab. Rep. 10: 345-349.
111. Norris, J.M., K. Barriga, G. Klingensmith, et al. 2003. Timing of initial cereal exposure in infancy and risk of islet autoimmunity. JAMA 290: 1713-1720.
112. Hummel, S., M. Pflüger, M. Hummel, et al. 2011. Primary dietary intervention study to reduce the risk of islet autoimmunity in children at increased risk for type 1 diabetes. Diabetes Care 34: 1301-1305.
113. Norris, J.M., K. Barriga, E.J. Hoffenberg, et al. 2005. Risk of celiac disease autoimmunity and timing of gluten introduction in the diet of infants at increased risk of disease. JAMA 293: 2343-2351.
114. Ludvigsson, J.F. & A. Fasano. 2012. Timing of introduction of gluten and celiac disease risk. Ann. Nutr. Metab. 60: 22-29.
115. Kimpimäki, T., M. Erkkola, S. Korhonen, et al. 2001. Short-term exclusive breastfeeding predisposes young children with increased genetic risk of type I diabetes to progressive beta-cell autoimmunity. Diabetologia 44: 63-69.
116. TRIGR Study Group. 2007. Study design of the Trial to Reduce IDDM in the Genetically at Risk (TRIGR). Pediatr. Diabet. 8: 117-137.
117. Akerblom, H.K., S.M. Virtanen, J. Ilonen, et al. 2005. Dietary manipulation of beta cell autoimmunity in infants at increased risk of type 1 diabetes: a pilot study. Diabetologia 48: 829-837.
118. Knip, M., S.M. Virtanen, D. Becker, et al. 2011. Early feeding and risk of type 1 diabetes: experiences from the Trial to Reduce Insulin-dependent diabetes mellitus in the Genetically at Risk (TRIGR). Am. J. Clin. Nutr. 94: 1814S-1820S.
119. Vaarala, O., J. Ilonen, T. Ruohtula, et al. 2012. Removal of bovine insulin from cow's milk formula and early initiation of beta-cell autoimmunity in the FINDIA Pilot Study. Arch. Pediatr. Adolesc. Med. 166: 608-614.
120. Vaarala, O., M. Knip, J. Paronen, et al. 1999. Cow's milk formula feeding induces primary immunization to insulin in infants at genetic risk for type 1 diabetes. Diabetes 48: 1389-1394.
121. Glimcher, L.H., J.A. Schroer, C. Chan, et al. 1983. Fine specificity of cloned insulin-specific T cell hybridomas: evidence supporting a role for tertiary conformation. J. Immunol. 131: 2868-2874.
122. Diaz, J.L. & T. Wilkin. 1987. Differences in epitope restriction of autoantibodies to native human insulin (IAA) and antibodies to heterologous insulin (IA). Diabetes 36: 66-72.
123. Vaarala, O., M.A. Atkinson & J. Neu. 2008. The "perfect storm" for type 1 diabetes: the complex interplay between intestinal microbiota, gut permeability, and mucosal immunity. Diabetes 57: 2555-2562.
124. Wilkin, T.J. 2001. The accelerator hypothesis: weight gain as the missing link between type I and type II diabetes. Diabetologia 44: 914-922.
125. Couper, J.J., S. Beresford, C. Hirte, et al. 2009. Weight gain in early life predicts risk of islet autoimmunity in children with a first-degree relative with type 1 diabetes. Diabetes Care 32: 94-99.
126. Fourlanos, S., P. Narendran, G.B. Byrnes, et al. 2004. Insulin resistance is a risk factor for progression to type 1 diabetes. Diabetologia 47: 1661-1667.
127. Xu, P., D. Cuthbertson, C. Greenbaum, et al. 2007. Role of insulin resistance in predicting progression to type 1 diabetes. Diabetes Care 30: 2314-2320.
128. Mrena, S., S.M. Virtanen, P. Laippala, et al. 2006. Models for predicting type 1 diabetes in siblings of affected children. Diabetes Care 29: 662-667.
129. Bingley, P.J., J.L. Mahon & E.A. Gale. 2008. insulin resistance and progression to type 1 diabetes in the European Nicotinamide Diabetes Intervention Trial (ENDIT). Diabetes Care 31: 146-150.
130. Lamb, M.M., X. Yin, G.O. Zerbe, et al. 2009. Height growth velocity, islet autoimmunity and type 1 diabetes development: the Diabetes Autoimmunity Study in the Young. Diabetologia 52: 2064-2071.
131. Winkler, C., S. Marienfeld, M. Zeilling, et al. 2009. Is islet autoimmunity related to insulin sensitivity or body weight in children of parents with type 1 diabetes? Diabetologia 52: 2072-2078.
132. Rewers, M. 2012. The fallacy of reduction. Pediatr. Diabetes 13: 340-343.